Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
19 October 2021 | Story Leonie Bolleurs | Photo Supplied
Prof Arno Hugo was recently elected as Vice-Chair of the Professional Advisory Committee (PAC) for Food Science in the SACNASP.

Prof Arno Hugo from the Department of Animal Science at the University of the Free State (UFS) was recently elected as Vice-Chair of the Professional Advisory Committee (PAC) for Food Science in the South African Council for Natural Scientific Professions (SACNASP).

SACNASP, similar to other professional bodies, is the registration, regulatory and enabling body for natural science professionals. The Natural Scientific Professions Act, 2003 (Act 27 of 2003) mandates SACNASP to register practising natural scientists in one of various fields of practice. Food science is one of 26 fields of practice gazetted for natural science.

Acknowledged as experienced professional

As Vice-Chair of the PAC, Prof Hugo – who is familiar with the processes – is acknowledged as an experienced professional to evaluate applications in this field of practice, where candidates apply for professional registration in Food Science.

He explains that the Advisory Committee ensures that candidates have adequate and relevant training in the natural sciences and in the field of food science. “For registration as professional natural scientist in this specific field, the appropriately qualified candidates must also have one to three years of working experience in the food industry, depending on the level of their food science qualification,” he says. 

Prof Hugo is also involved in interviewing candidates who want to register as professional food scientists via the route of recognition of prior learning (RPL). “Candidates with relevant qualifications can also register as professional food scientists via RPL if they have 10 years of working experience in this field,” he states.

Furthermore, he also evaluates the qualifications and work experience of foreign nationals applying for critical skills visas to work as food scientists in South Africa, due to a shortage of food scientists in South Africa. 

Food safety – a basic human right

According to Prof Hugo, consumers should not have to hope and trust that their food is safe to consume.

Food safety is internationally regarded as a basic human right. Prof Hugo says people must have access to clean (meaning safe) food and water at all times. “When food processing and preservation activities are performed at commercial level, or food – including processed food – is traded to consumers who have no control over the process, the consumers should not only ‘trust’ that their food is safe to be consumed after processing. 

“There need to be processes in place to ensure that consumers are served safe food and water.”

He believes that in order to achieve this, only sufficiently trained and registered scientists should be responsible for ensuring that food safety and quality principles are always applied and adhered to during the manufacture of food products.

“Individuals who want to work in this space must therefore show training and competency to take responsibility for risks such as food spoilage or food poisoning. We all remember the 2018 outbreak of Listeria in the meat processing industry, which caused the death of 200 consumers,” he adds. 

Importance of quality education and lifelong learning skills

Prof Hugo is of the opinion that it is very important that education and lifelong learning skills, through continuing professional development (CPD), are of a high standard and are available to scientists who are contributing to the country's growth, as well as social and economic development.

“The Minister of Higher Education, Science and Technology consults a statutory body such as the SACNASP for input on the science professions. SACNASP is also mentioned in the White Paper on Science and Technology as the custodian of CPD, through which additional skills/re-skilling of scientists are conducted,” he explains.

He says some of the advantages of being registered as a professional natural scientist with SACNASP include that you are recognised as a professional; there is public confidence in you as a scientist, you are more marketable; and you adhere to a code of conduct (you are trusted for ethical values).

Regarding the work he is doing as the Vice-Chair of the Professional Advisory Committee (PAC), Prof Hugo says: “I consider this voluntary work as a privilege and part of my community service to the industry that employs our students.”

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept